
About 4ADI
4ADI is a Healthcare company based in San Antonio (United States) founded in 1993. It provides antibodies, ELISA kits, and reagents for biomedical research and diagnostics. It operates on a B2B and Direct Sales model. The company has 17 employees. 4ADI offers products and services including Primary Antibodies, ELISA Kits, Secondary Antibodies, TruStrip Rapid Tests, and Custom Peptides. Its focus areas include Biotech, Research Tools, Antibodies and Custom Peptides. Its legal entity is ALPHA DIAGNOSTIC INTERNATIONAL, INC. Its competitors include PrognomiQ, List Biological Laboratories and ACRO Biosystems; 2 of its 3 listed competitors have raised funding.
Company details
Alpha Diagnostic International Inc. specializes in offering custom peptides, antibodies, and ELISA kits for infectious disease research and vaccine development. The company operates through an online platform, allowing customers to request quotes and purchase products like primary antibodies and rapid tests. Based in San Antonio, Texas, USA, it serves researchers, pharmaceutical companies, and healthcare providers with tools for ELISA, Western blotting, and other diagnostic applications, focusing on quality and innovation in biotechnology.
- Employee Count17
Products & Services of 4ADI
4ADI offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, Secondary Antibodies, TruStrip Rapid Tests, and Custom Peptides.
Antibodies used for scientific research and diagnostics applications
Kits for detecting infectious diseases and proteins quantitatively
Antibodies that enhance detection in immunoassays
Rapid tests for sample transfer and disease screening
Custom-designed peptides for research and therapeutic use
Competitors of 4ADI
4ADI has 3 listed competitors in our database, 2 of them funded. They include PrognomiQ, List Biological Laboratories and ACRO Biosystems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| listlabs.com | 1978 | Campbell, United States | $48.4M | Specializes in the production of research reagents | ||
| acrobiosystems.com | 2016 | Newark, United States | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. |
Detailed competitors of 4ADI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 4ADI
Websites that share an audience with 4ADI (4adi.com).
Websites whose visitors overlap most with 4ADI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genovis.com | 100% | 9.2K | #2,548,590 | View details | |
| qedbio.com | 100% | 4.9K | #3,910,628 | View details | |
| cygnustechnologies.com | 85% | 8K | #2,705,520 | View details | |
| absoluteantibody.com | 78% | 34.2K | #944,741 | View details | |
| diasource-diagnostics.com | 70% | 1.9K | #8,195,239 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 12 similar websites and full traffic analytics for 4ADI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as 4ADI (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 4ADI
4ADI was founded in 1993.
4ADI is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
4ADI has 17 employees.
Alpha Diagnostic International Inc. specializes in offering custom peptides, antibodies, and ELISA kits for infectious disease research and vaccine development. The company operates through an online platform, allowing customers to request quotes and purchase products like primary antibodies and rapid tests. Based in San Antonio, Texas, USA, it serves researchers, pharmaceutical companies, and healthcare providers with tools for ELISA, Western blotting, and other diagnostic applications, focusing on quality and innovation in biotechnology.
4ADI's top competitors include PrognomiQ, ACRO Biosystems and List Biological Laboratories.
4ADI offers Primary Antibodies, ELISA Kits, Secondary Antibodies, TruStrip Rapid Tests, and Custom Peptides.
4ADI operates through Alpha Diagnostic International, Inc..